Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4985957_AE85957_0